Log in

NASDAQ:ACRSAclaris Therapeutics Earnings Date, Estimates & History

+0.18 (+10.00 %)
(As of 07/10/2020 04:00 PM ET)
Today's Range
Now: $1.98
50-Day Range
MA: $1.48
52-Week Range
Now: $1.98
Volume1.27 million shs
Average Volume605,667 shs
Market Capitalization$82.89 million
P/E RatioN/A
Dividend YieldN/A


Aclaris Therapeutics (NASDAQ:ACRS) Earnings Information

Aclaris Therapeutics last announced its quarterly earnings results on May 7th, 2020. The biotechnology company reported ($0.37) earnings per share for the quarter, missing the consensus estimate of $0.01 by $0.38. The firm had revenue of $1.41 million for the quarter, compared to analysts' expectations of $1.27 million. Aclaris Therapeutics has generated ($2.25) earnings per share over the last year. Aclaris Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 13th, 2020 based off prior year's report dates.

Aclaris Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Aclaris Therapeutics (NASDAQ:ACRS) Earnings Estimates

2020 EPS Consensus Estimate: ($1.90)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202($0.83)($0.28)($0.56)
Q2 20203($0.68)($0.34)($0.45)
Q3 20203($0.69)($0.34)($0.46)
Q4 20203($0.61)($0.34)($0.43)

Aclaris Therapeutics (NASDAQ ACRS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/7/2020Q1 2020$0.0050($0.3745)($0.35)$1.27 million$1.41 millionN/A
2/25/2020Q4 2019($0.34)($0.46)($0.47)$0.10 million$1.10 millionN/A
11/7/2019Q3($0.54)($1.34)$0.22$5.87 million$0.98 millionTranscript
8/8/2019Q2 2019($0.77)($0.72)($0.23)$5.77 million$5.87 millionN/A
5/8/20193/31/2019($0.86)($0.91)($0.91)$5.13 million$5.04 millionTranscript
3/18/2019Q4($0.96)($0.99)($0.99)$4.40 million$3.67 millionTranscript
11/6/20189/30/2018($1.25)($1.06)($1.06)$1.58 million$1.63 millionN/A
8/3/2018Q2 2018($1.0520)($1.01)($1.01)$2.76 million$3.68 millionN/A
5/8/2018Q1 2018($1.00)($0.98)($0.98)$1.00 million$1.12 millionN/A
3/12/2018Before Market($0.90)($0.80)($0.86)$0.80 million$1.00 millionTranscript
11/7/2017Q3 2017($0.86)($0.63)($0.63)$2.00 million$0.68 millionN/A
8/8/2017Q2 2017($0.68)($0.56)($0.56)Listen
5/9/2017Q1 2017($0.54)($0.48)($0.48)Listen
3/15/2017Q4 2016($0.59)($0.4910)($0.49)N/A
11/18/2015Q3 2015($1.46)($5.11)($5.11)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.